Hologic
Breast cancer: Hologic touts ‘excellent’ results from 7-year MammoSite registry
Hologic lands $32.3M max Defense Dept. contract extension
Hologic takes SenoRx assets in out-of-court settlement with C.R. Bard
Hologic beats its own Q3 earnings guidance, lowers outlook
Hologic’s femur fracture test wins FDA clearance
Ex-CEO Cumming is back in Hologic’s corner office as Cascella steps down
Women’s health: Smith & Nephew win over Hologic stands, damages TBD
Breast cancer: Hologic wins FDA approval for new mammography software
Hologic (NSDQ:HOLX) won pre-market approval from the FDA for mammography software it says will help reduce patients’ exposure to radiation.
The Bedford, Mass.-based women’s health company said its C-View 2D imaging software is meant to replace conventional 2D exposure, a component of Hologic’s 3D 3D breast tomosynthesis mammography system.
Medical device tax: How much are companies paying to government for healthcare reform?
In January 2013, Medical device companies began paying a 2.3% excise tax on U.S. Sales in order to pay for the Patient Protection and Affordable Care Act.
The levy is expected to generate some $30 billion over the next 10 years.
MassDevice.com is tracking the tally paid by several medical device companies, based on quarterly earnings report for the first quarter of 2013. We will update the list as more companies returns file in.
Tallies based on companies with Q1 earnings ended on March 31, 2013